Company Profile-Shandong Keyuan Pharmaceutical Co., Ltd. - Building a Multi dimensional Symbiosis Biomedical Enterprise

Shandong Keyuan Pharmaceutical Co.,Ltd.

Shandong Keyuan Pharmaceutical Co., Ltd. (Stock Code: 301281.SZ), established in 2004, is a leading enterprise in the domestic chemical raw material pharmaceutical sector. It focuses on the R&D, production, and sales of chemical raw materials and formulations, and was listed on the Shenzhen Stock Exchange's ChiNext board in April 2023. The company focuses on the essential needs of chronic disease treatments such as neuropsychiatric, cardiovascular, diabetic, and respiratory diseases. Its core products have successively passed international authoritative certifications such as the US FDA, EU CEP, Korean MFDS, and Japanese PMDA, and are sold in dozens of countries and regions worldwide.

Its wholly-owned subsidiary, Linuo Pharmaceutical, focuses on chemical formulation business. Leveraging the synergistic advantages of integrated raw material and formulation, and integrated excipient and formulation, its products cover various dosage forms including oral solid/liquid preparations, injections, drops, liniments, pastes, and sprays, comprehensively meeting market demands.

The company actively promotes intelligent manufacturing and green production, and has now established three major intelligent manufacturing bases: Shanghe for APIs, Jinan for injectables, and Yinan for oral solid/liquid dosage forms. It has also launched key projects such as a continuous flow intelligent factory and a flexible biomanufacturing factory, accelerating the formation of a "diversified and symbiotic" industrial structure. Once fully operational, these bases will ensure a stable and high-quality product supply.

The company adheres to the core values of "long-termism, product-centricity, and altruism," and adopts a "1+3" development strategy. It is consolidating its industrial foundation, actively exploring and developing cutting-edge fields such as blood sugar control and weight loss products, anti-aging products, and brain-computer interfaces, perfecting its full-scenario product system, deepening its presence in the domestic market, accelerating its global expansion, and striving to become a technologically advanced, fully integrated, and internationally aligned modern pharmaceutical company.

2004 Year

Company Establishment Time

301281 .SZ

Stock Code

500 +

Professional and technical personnel

20 Province/City

Products are available nationwide

Focus on Core Tracks, Explore Diversified Growth

In the face of industry changes and challenges, Keyuan Pharmaceutical uses the fusion and innovation of chemical and biological synthesis technologies as its driving force, continuously strengthening its competitive advantages in the fields of anti-diabetic, cardiovascular, and central nervous system chronic diseases. At the same time, it actively expands into emerging business areas such as cosmetic raw materials, high-end pharmaceutical excipients, and functional food additives, building an industrial ecosystem of "raw materials + multi-field synergy. Its wholly-owned subsidiary, Shandong LINO Pharmaceutical Co., Ltd., focuses on the R&D, production, and sales of chemical pharmaceutical preparations. It has established a rich product line in the field of chronic diseases and accumulated strong R&D capabilities. Keyuan Pharmaceutical, together with LINO Pharmaceutical, has built a complete industrial system that integrates raw materials and preparations, excipients and preparations, and the entire upstream and downstream chain, gradually expanding its market competitive advantages.

Technology-Driven, Innovation Breakthrough

Keyuan Pharmaceutical regards innovative R&D as its lifeline, establishing a dual-engine R&D system that combines independent research with external collaboration. Internally, leveraging platforms such as a provincial-level enterprise technology center and a postdoctoral innovation practice base, the company has built an international R&D team focused on achieving breakthroughs in key areas—including green synthesis processes, formulation improvements, and biotechnology applications. Externally, it engages in deep cooperation with top-tier domestic and international R&D institutions to advance the innovation of improved new drugs, peptide drugs, and small nucleic acid drugs, thereby accelerating the commercialization of technological achievements and fostering new growth drivers.

Quality Foundation, Global Certification

Keyuan Pharmaceutical integrates the philosophy that "quality represents self-respect and life itself" throughout its entire industry chain. The company has established a market-oriented quality management system aligned with international standards, ensuring that every product meets high benchmarks from R&D through to delivery. Thanks to this comprehensive and rigorous quality management system, Keyuan Pharmaceutical has earned widespread recognition in both domestic and international markets; its core products have secured prestigious international certifications—including US FDA, EU CEP, and South Korea MFDS—enabling the company to provide safe, reliable, and high-quality products and services to customers worldwide.

Green Manufacturing, Global Layout

Keyuan Pharmaceutical is accelerating its digital and intelligent transformation by establishing three major production bases—an API facility in Shanghe, an injectable drug facility in Jinan, and an oral solid/liquid dosage form facility in Yinan. The company is building a world-class intelligent manufacturing system and leveraging AI technology to empower R&D, production, and quality management. By ensuring product quality and supply stability from the source, it demonstrates the robust quality associated with "Intelligent Manufacturing in China." In the international market, the company is vigorously implementing its "Five-Force Strategy": solidifying its foundation through product excellence, driving growth through innovation, building a strong reputation through quality, earning trust through reliable delivery, and leading the future through sustainability. This strategy continuously fuels global market expansion and the creation of a professional, efficient service network. Looking ahead, the company will accelerate its international strategic layout, serving the global life and health sector with a diversified product portfolio, and striving to become a sustainable pharmaceutical enterprise with strong international competitiveness.

Keyuan Pharmaceutical—guarding health with technology, creating the future with symbiosis! The company will continue to cultivate the domestic market, accelerate the expansion of its global business map, comprehensively enhance its brand value and international influence, and continuously inject new vitality into the global life and health industry! Keyuan Pharmaceutical is not only an explorer of pharmaceutical technology but also a creator of a healthy future.

Certificate of Honor National Standard Undertaken Projects